I 
118TH CONGRESS 
2D SESSION 
H. R. 8999 
To amend title XVIII of the Social Security Act to provide coverage and 
payment under such title for certain treatments for dialysis-related amy-
loidosis, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 11, 2024 
Mr. BABIN (for himself, Mr. NADLER, and Mr. VALADAO) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committee on Ways and Means, for a pe-
riod to be subsequently determined by the Speaker, in each case for con-
sideration of such provisions as fall within the jurisdiction of the com-
mittee concerned 
A BILL 
To amend title XVIII of the Social Security Act to provide 
coverage and payment under such title for certain treat-
ments for dialysis-related amyloidosis, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Dialysis-Related Amy-
loidosis Treatment Act of 2024’’. 
VerDate Sep 11 2014 
03:21 Aug 16, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8999.IH
H8999
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SEC. 2. COVERAGE AND PAYMENT FOR TREATMENTS FOR 
DIALYSIS-RELATED 
AMYLOIDOSIS 
UNDER 
THE MEDICARE PROGRAM. 
(a) COVERAGE.—Section 1861(s)(2) of the Social Se-
curity Act (42 U.S.C. 1395x(s)(2)), is amended— 
(1) in subparagraph (JJ), by inserting ‘‘and’’ 
at the end; and 
(2) by adding at the end the following new sub-
paragraph: 
‘‘(KK) treatments for dialysis-related amyloi-
dosis (as defined in subsection (nnn));’’. 
(b) TREATMENTS FOR DIALYSIS-RELATED AMYLOI-
DOSIS DEFINED.— 
(1) IN GENERAL.—Section 1861 of the Social 
Security Act (42 U.S.C. 1395x), is amended by add-
ing at the end the following new subsection: 
‘‘(nnn) TREATMENTS FOR DIALYSIS-RELATED AMY-
LOIDOSIS.—The term ‘treatments for dialysis-related amy-
loidosis’ means any item or service that is furnished in 
a dialysis facility (freestanding or hospital-based) that is 
approved by the Food and Drug Administration for the 
treatment of dialysis-related amyloidosis, and any supplies 
or services that are provided adjunct to and are necessary 
for such treatment.’’. 
(2) EXCLUSION FROM RENAL DIALYSIS SERV-
ICES.—Section 1881(b)(14)(B) of the Social Secu-
VerDate Sep 11 2014 
03:21 Aug 16, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8999.IH
H8999
kjohnson on DSK7ZCZBW3PROD with $$_JOB
rity Act (42 U.S.C. 1395rr(b)(14)(B)) is amended 
by inserting before the period at the end the fol-
lowing: ‘‘or ‘treatments for dialysis-related amyloi-
dosis’ (as defined in section 1861(nnn))’’. 
(c) PAYMENT.—Section 1833(a)(1)(E) of the Social 
Security Act (42 U.S.C. 1395l(a)(1)(E)) is amended by 
inserting at the end the following: ‘‘except for treatments 
for dialysis-related amyloidosis, which may not be included 
as a renal dialysis service for purposes of payment under 
any prospective payment amount or comprehensive fee es-
tablished under section 1881, and for which payment shall 
be made separately in the amount of 100 percent of the 
reasonable charges for such items and services,’’. 
(d) EFFECTIVE DATE.—The amendments made by 
this section shall take effect on the date of the enactment 
of this Act. 
Æ 
VerDate Sep 11 2014 
03:21 Aug 16, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H8999.IH
H8999
kjohnson on DSK7ZCZBW3PROD with $$_JOB